Office of the Commissioner of Lobbying of Canada Office of the Commissioner of Lobbying of Canada

Language selection

Registry of Lobbyists

Patented Medicine Prices Review Board (PMPRB) in Active Registrations on: 2022-04-30

Other options for searching the Registry: 12-Month Lobbying Activity Search; Advanced Registry Search; Recent Registrations; and Recent Monthly Communication Reports.

Results 51-100 of 114

  • Boehringer Ingelheim (Canada) Ltd.
    Consultant: Lily Mesh, Wellington Dupont Public Affairs
    Posted date: 2022-01-25
    Submission type: New View new registration
  • Johnson & Johnson Family of Companies In Canada
    Consultant: Stephen Sampson, Global Public Affairs
    Posted date: 2022-01-24
    Submission type: Update View updated registration
  • The Canada Life Assurance Company / de la Compagnie d'Assurance du Canada sur la Vie
    In-house Corporation: Paul Mahon, President and Chief Executive Officer
    Posted date: 2022-01-20
    Submission type: Update View updated registration
  • Retail Council of Canada / Conseil canadien du commerce de detail
    In-house Organization: Diane J. Brisebois, President & Chief Executive Officer
    Posted date: 2022-01-20
    Submission type: Update View updated registration
  • GlaxoSmithKline Inc.
    Consultant: Sheamus Murphy, Counsel Public Affairs Inc.
    Posted date: 2022-01-20
    Submission type: Update View updated registration
  • GlaxoSmithKline Inc.
    Consultant: David Murray, Counsel Public Affairs Inc.
    Posted date: 2022-01-20
    Submission type: Update View updated registration
  • GlaxoSmithKline Inc.
    Consultant: Ben Parsons, Counsel Public Affairs Inc.
    Posted date: 2022-01-20
    Submission type: Update View updated registration
  • Takeda Canada Inc.
    Consultant: Johnathan Rix, Santis Health Inc.
    Posted date: 2022-01-18
    Submission type: New View new registration
  • Neighbourhood Pharmacy Association
    In-house Organization: Sandra Hanna, Chief Executive Officer
    Posted date: 2022-01-17
    Submission type: Update View updated registration
  • Innovative Medicines Canada
    Consultant: Don Boudria, HILL+KNOWLTON STRATEGIES
    Posted date: 2022-01-14
    Submission type: Update View updated registration
  • AstraZeneca Canada Inc.
    In-house Corporation: Kiersten Combs, President
    Posted date: 2022-01-13
    Submission type: Update View updated registration
  • XpertVR Inc.
    Consultant: Fernando Minna, The Capital Hill Group
    Posted date: 2022-01-12
    Submission type: New View new registration
  • Sandoz Canada Inc.
    In-house Corporation: Michel Robidoux, President & Chief Executive Officer
    Posted date: 2022-01-07
    Submission type: Update View updated registration
  • 9795855 Canada Inc.
    In-house Corporation: Paul Spark, Co Founder
    Posted date: 2022-01-05
    Submission type: Update View updated registration
  • AbbVie Corporation
    Consultant: Stephanie Levee, 3Sixty Public Affairs Inc.
    Posted date: 2022-01-04
    Submission type: New View new registration
  • Cystic Fibrosis Canada / Fibrose kystique Canada
    In-house Organization: Kelly Grover, President and Chief Executive Officer
    Posted date: 2022-01-04
    Submission type: Update View updated registration
  • Arthritis Society Canada / Société de l’arthrite du Canada
    Consultant: WILLIAM DEMPSTER, 3Sixty Public Affairs Inc.
    Posted date: 2021-12-21
    Submission type: Update View updated registration
  • RAREi - The Canadian Forum for Rare Disease Innovators / iRARE, le Forum canadien des innovateurs spécialisés dans les maladies rares
    Consultant: GERALD JEFFCOTT, 3Sixty Public Affairs
    Posted date: 2021-12-20
    Submission type: Update View updated registration
  • Novartis Pharmaceuticals Canada Inc.
    In-house Corporation: Christian Macher, Country President & Oncology General Manager Canada
    Posted date: 2021-12-16
    Submission type: Update View updated registration
  • The Ontario Lung Association
    In-house Organization: George Habib, CEO
    Posted date: 2021-12-16
    Submission type: Update View updated registration
  • Pfizer Canada ULC
    In-house Corporation: Cole C. Pinnow, President
    Posted date: 2021-12-16
    Submission type: Update View updated registration
  • McKesson Canada
    Consultant: Jesse Shea, Enterprise Canada
    Posted date: 2021-12-08
    Submission type: New View new registration
  • HIV Legal Network / Réseau juridique VIH
    In-house Organization: Sandra Ka Hon Chu, Co-Executive Director
    Posted date: 2021-12-07
    Submission type: Update View updated registration
  • Vertex Pharmaceuticals (Canada) Incorporated
    In-house Corporation: Michael Siauw, General Manager – Canada
    Posted date: 2021-12-01
    Submission type: Update View updated registration
  • Accelera Canada Ltd.
    Consultant: Stephen Sampson, Global Public Affairs
    Posted date: 2021-11-30
    Submission type: New View new registration
  • Familiprix inc.
    In-house Corporation: Albert Falardeau, Président
    Posted date: 2021-10-26
    Submission type: Update View updated registration
  • Canadian Health Research Forum / Le forum de la recherche canadienne en santé
    Consultant: Philip Delistoyanov, 3Sixty Public Affairs
    Posted date: 2021-10-21
    Submission type: Reactivation View reactivated registration
  • Merck Canada Inc.
    In-house Corporation: Marwan Akar, PRESIDENT
    Posted date: 2021-10-18
    Submission type: Update View updated registration
  • Neighbourhood Pharmacy Association of Canada (Neighbourhood Pharmacies) / Association canadienne des pharmacies de quartier
    Consultant: Michelle McLean, Hill+Knowlton Strategies
    Posted date: 2021-10-01
    Submission type: Update View updated registration
  • Institute for Advancements in Mental Health
    In-house Organization: Mary Alberti, Chief Executive Officer
    Posted date: 2021-10-01
    Submission type: Update View updated registration
  • BIOTECANADA
    In-house Organization: ANDREW CASEY, President & CEO
    Posted date: 2021-09-20
    Submission type: Update View updated registration
  • Innovative Medicines Canada
    Consultant: Kevin Bosch, Hill+Knowlton Strategies
    Posted date: 2021-09-02
    Submission type: Update View updated registration
  • Canadian Animal Health Institute / Institut canadien de la santé animale
    Consultant: Kevin Bosch, Hill+Knowlton Strategies
    Posted date: 2021-09-01
    Submission type: Update View updated registration
  • Centre de recherche pharmaceutique de Luozi (CRPL)
    Consultant: Claude Kazadi Lubatshi
    Posted date: 2021-08-30
    Submission type: Update View updated registration
  • Innovative Medicines Canada
    Consultant: Will Stewart, Hill+Knowlton Strategies
    Posted date: 2021-08-27
    Submission type: Update View updated registration
  • Horizon Therapeutics Canada
    Consultant: Stephen Sampson, Global Public Affairs
    Posted date: 2021-08-24
    Submission type: Update View updated registration
  • Canadian Animal Health Institute / Institut canadien de la santé animale
    Consultant: Laura Grosman, HILL + KNOWLTON STRATEGIES
    Posted date: 2021-08-23
    Submission type: New View new registration
  • Life Sciences Ontario (LSO)
    In-house Corporation: Jason Field, President & CEO
    Posted date: 2021-08-13
    Submission type: Update View updated registration
  • Teva Canada Limited / Teva Canada Limitee
    In-house Corporation: Christine Poulin, Senior Vice President and General Manager
    Posted date: 2021-08-13
    Submission type: Update View updated registration
  • Canadian Health Research Forum (CHRF) / Le forum canadien de la recherche en santé (FCRS)
    Consultant: WILLIAM DEMPSTER, 3Sixty Public Affairs Inc.
    Posted date: 2021-08-09
    Submission type: Update View updated registration
  • Gilead Sciences Canada Inc.
    Consultant: Greg Maceachern, Proof Strategies / Proof Stratégies
    Posted date: 2021-07-19
    Submission type: New View new registration
  • Canadian Organization for Rare Disorders
    Consultant: Johanne Chambers, 3Sixty Public Affairs Inc.
    Posted date: 2021-07-16
    Submission type: Update View updated registration
  • CanAge
    In-house Organization: Laura Tamblyn Watts, Chief Executive Officer
    Posted date: 2021-07-06
    Submission type: Update View updated registration
  • The Canadian Lung Association / L'Association pulmonaire du Canada
    In-house Organization: Terrance Dean, President and Chief Executive Officer
    Posted date: 2021-06-30
    Submission type: Update View updated registration
  • Gilead Sciences Canada
    In-house Corporation: Melissa Koomey, V.P. and General Manager
    Posted date: 2021-05-31
    Submission type: Update View updated registration
  • Canadian Generic Pharmaceutical Association (CGPA) / L'Association canadienne du médicament générique (ACMG)
    In-house Organization: JAMES KEON, PRESIDENT
    Posted date: 2021-05-07
    Submission type: Update View updated registration
  • Innovative Medicines Canada
    Consultant: Michelle McLean, Hill+Knowlton Strategies
    Posted date: 2021-04-29
    Submission type: Update View updated registration
  • Biogen Canada
    Consultant: Ben Parsons, Counsel Public Affairs Inc.
    Posted date: 2021-04-07
    Submission type: Update View updated registration
  • Biogen Canada
    Consultant: David Murray, Counsel Public Affairs Inc.
    Posted date: 2021-04-07
    Submission type: Update View updated registration
  • Biogen Canada
    Consultant: Sheamus Murphy, Counsel Public Affairs Inc.
    Posted date: 2021-04-07
    Submission type: Update View updated registration
Return to Government Institutions in Active Registrations
Date Modified: